KUVATRIS THERAPEUTICS, INC. Interest Expense
KUVATRIS THERAPEUTICS, INC. reported Interest Expense of $9.16 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-09-20
- KUVATRIS THERAPEUTICS, INC. interest expense for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- KUVATRIS THERAPEUTICS, INC. interest expense for the quarter ending 2023-09-30 was $1.31K, a 0.00% change year-over-year.
- KUVATRIS THERAPEUTICS, INC. interest expense for the quarter ending 2023-06-30 was $3.93K.
- KUVATRIS THERAPEUTICS, INC. interest expense for the quarter ending 2023-03-31 was $3.93K.
- KUVATRIS THERAPEUTICS, INC. interest expense for fiscal 2023 was $9.16K, a 75.00% increase from fiscal 2022.
- KUVATRIS THERAPEUTICS, INC. interest expense for fiscal 2022 was $5.24K, a 99.81% decline from fiscal 2021.
- KUVATRIS THERAPEUTICS, INC. interest expense for fiscal 2021 was $2.81M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $1.31K derived: sum of 2 quarters · filed 2024-03-11 | $5.24K derived: sum of 3 quarters · filed 2024-09-20 | $9.16K 10-K · filed 2024-03-11 |
| 2023-09-30 | $1.31K 10-Q · filed 2023-11-16 | $5.24K derived: sum of 2 quarters · filed 2024-09-20 | $9.16K 10-Q · filed 2023-11-16 | $13.09K derived: sum of 4 quarters · filed 2024-09-20 |
| 2023-06-30 | $3.93K 10-Q · filed 2024-09-20 | $7.86K 10-Q · filed 2024-09-20 | $11.78K derived: sum of 3 quarters · filed 2024-09-20 | $13.09K derived: sum of 4 quarters · filed 2024-09-20 |
| 2023-03-31 | $3.93K 10-Q · filed 2024-05-13 | $7.86K derived: sum of 2 quarters · filed 2024-05-13 | $9.16K derived: sum of 3 quarters · filed 2024-05-13 | |
| 2022-12-31 | $3.93K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $5.24K derived: sum of 2 quarters · filed 2024-03-11 | $5.24K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $1.31K 10-Q · filed 2023-11-16 | $1.31K 10-Q · filed 2023-11-16 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $2.81M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.81M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $2.81M 10-Q · filed 2022-09-30 |